Shandong Xinhua Pharmaceutical Company Limited Cash Flow Conversion Efficiency

Latest as of September 2023: 0.012x

Shandong Xinhua Pharmaceutical Company Limited cash flow conversion efficiency. Based on the latest financial reports, Shandong Xinhua Pharmaceutical Company Limited (XIN) has a cash flow conversion efficiency ratio of 0.012x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€56.11 Million ≈ $65.60 Million USD) by net assets (€4.70 Billion ≈ $5.50 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shandong Xinhua Pharmaceutical Company Limited (2013–2025)

Cash flow conversion efficiency of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. This chart illustrates how Shandong Xinhua Pharmaceutical Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Xinhua Pharmaceutical Company L (XIN) share price today for real-time trading data and today's change.

Shandong Xinhua Pharmaceutical Company Limited Cash Flow Conversion Ratio Explained

Shandong Xinhua Pharmaceutical Company Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shandong Xinhua Pharmaceutical Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Xinhua Pharmaceutical Company Limited ranked by their cash flow conversion efficiency. Also see Shandong Xinhua Pharmaceutical Company L market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Cheops Technology France SA
PA:MLCHE
N/A
Mega Uranium Ltd.
TO:MGA
-0.005x
SPRINGFIELD PROP. LS-125
F:9MZ
N/A
Walchandnagar Industries Limited
NSE:WALCHANNAG
0.034x
Kustur Kusadasi Turizm Endustrisi AS
IS:KSTUR
0.056x
S&P Syndicate Public Company Limited
BK:SNP
0.106x
EDAP TMS S.A
F:EDA
1.144x
Silicon Optronics Inc
TW:3530
0.056x

Annual Cash Flow Conversion Efficiency for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. Review Shandong Xinhua Pharmaceutical Company L (XIN) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €5.46 Billion
≈ $6.38 Billion
€533.73 Million
≈ $623.98 Million
0.098x +38.85%
2024-12-31 €5.22 Billion
≈ $6.10 Billion
€367.61 Million
≈ $429.78 Million
0.070x +26.84%
2023-12-31 €4.78 Billion
≈ $5.58 Billion
€265.28 Million
≈ $310.14 Million
0.056x -68.13%
2022-12-31 €4.35 Billion
≈ $5.09 Billion
€758.24 Million
≈ $886.46 Million
0.174x +145.62%
2021-12-31 €3.65 Billion
≈ $4.27 Billion
€259.12 Million
≈ $302.93 Million
0.071x -42.72%
2020-12-31 €3.39 Billion
≈ $3.96 Billion
€420.19 Million
≈ $491.24 Million
0.124x +10.66%
2019-12-31 €3.11 Billion
≈ $3.64 Billion
€348.27 Million
≈ $407.17 Million
0.112x -3.33%
2018-12-31 €2.80 Billion
≈ $3.27 Billion
€323.91 Million
≈ $378.68 Million
0.116x -23.39%
2017-12-31 €2.58 Billion
≈ $3.02 Billion
€389.97 Million
≈ $455.92 Million
0.151x -28.45%
2016-12-31 €2.08 Billion
≈ $2.43 Billion
€439.35 Million
≈ $513.64 Million
0.211x +20.25%
2015-12-31 €1.98 Billion
≈ $2.32 Billion
€348.64 Million
≈ $407.59 Million
0.176x -3.00%
2014-12-31 €1.91 Billion
≈ $2.24 Billion
€346.34 Million
≈ $404.91 Million
0.181x +224.96%
2013-12-31 €1.88 Billion
≈ $2.20 Billion
€104.99 Million
≈ $122.75 Million
0.056x --

About Shandong Xinhua Pharmaceutical Company Limited

F:XIN Germany Drug Manufacturers - Specialty & Generic
Market Cap
$132.23 Million
€113.10 Million EUR
Market Cap Rank
#17964 Global
#1680 in Germany
Share Price
€0.58
Change (1 day)
-0.85%
52-Week Range
€0.57 - €0.80
All Time High
€0.97
About

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing service… Read more